XFOR: X4 Pharmaceuticals, Inc. Stock

by  •  • Comments Off on XFOR: X4 Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 63.97
Enterprise Value ($M) 41.78
Book Value ($M) 59.62
Book Value / Share 0.35
Price / Book 1.07
NCAV ($M) 24.43
NCAV / Share 0.14
Price / NCAV 2.62

Profitability (mra)
Return on Invested Capital (ROIC) -0.12
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 4.80
Current Ratio 4.89

Balance Sheet (mrq) ($M)
Current Assets 142.97
Assets 178.16
Liabilities 118.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-31 13G/A Vanguard Group Inc 4.80 -2.84
11-08 13G BlackRock, Inc. 6.70 0.00
2024-02-14 13G Acorn Bioventures, L.p. 9.99
2024-02-14 13G/A Lincoln Park Capital Fund, LLC 0.95 -11.60
2024-02-14 13G/A Orbimed Advisors Llc 6.70 11.29
2024-02-13 13G/A Bain Capital Life Sciences Fund, L.P. 9.99 38.63

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 493,147 1,851,486 26.64
2025-03-06 145,900 807,323 18.07
2025-03-05 348,185 1,429,309 24.36
2025-03-04 388,010 1,463,637 26.51

(click for more detail)

Similar Companies
WINT – Windtree Therapeutics, Inc. XBIO – Xenetic Biosciences, Inc.
XCUR – Exicure, Inc. ZURA – Zura Bio Limited


Financial data and stock pages provided by
Fintel.io